author-photo

Hong-Shuai Li

Peking Union Medical College

5

Papers

4

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Remarkable response of BRAFV600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report

2021 Gastroenterology Report
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of pan-ErbB inhibitor pyrotinib combined with antiangiogenic agent apatinib for HER2-mutant or amplified metastatic NSCLC: A phase II clinical study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Adenosquamous carcinoma of the digestive system: a literature review.

2020 Scandinavian Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)